Exploration of the clinical interaction between vascular targeting agents and radiotherapy
Preclinical studies of vascular disruptive and anti-angiogenic agents, combined with radiation, have demonstrated the potential for enhanced anti-tumour activity. However, the optimal strategy and scheduling for combining these treatments with radiotherapy remains uncertain. In this thesis, combreta...
Main Author: | Mandeville, H. C. |
---|---|
Published: |
University College London (University of London)
2011
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.617904 |
Similar Items
-
Development of novel heterocyclic compounds as vascular targeting agents
by: Killoran, P. M.
Published: (2015) -
Biological and clinical evaluation of intensity modulated radiotherapy for brain tumours
by: Sivabalasingham, S.
Published: (2016) -
Novel radioimmunotherapy for lymphoma and solid tumours both as a single agent and in combination with the vascular disrupting agents
by: Dancey, G. S.
Published: (2011) -
Does aspirin enhance the clinical response to pre-operative chemo-radiotherapy in rectal cancer?
by: Gash, Katherine Jane
Published: (2016) -
The interaction of cetuximab with chemotherapeutic agents in colon cancer
by: Santoro, V.
Published: (2014)